You are here: Industry Insights > COVID-19

News List

90% of Chinese people vaccinated against COVID-19 NMPA/Xinhua
January 18, 2022
Over 1.26 billion Chinese people, or nearly 90 percent of the country's population, have received COVID-19 vaccine jabs as of Friday, said a health official on Saturday.
New testing kit able to detect 15 strains of novel coronavirus NMPA/China Daily
January 18, 2022
China approved a new COVID-19 testing kit on Saturday that can accurately diagnose 15 common strains of the novel coronavirus, including the Delta and Omicron variants, according to kit developer Tsinghua University.
IIT Mandi researchers discover phytochemicals in Himalayan plant that inhibit COVID-19 virus ExpressPharma
January 18, 2022
Researchers show that phytochemical-rich petals of Rhododendron arboreum found in the Himalayan region, locally called “Buransh” show antiviral activity and fight against the virus.
WHO recommends two new drugs to treat patients with COVID-19 WorldPharmaNews
January 18, 2022
The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids...
White House Launches Website for Free Home COVID-19 Tests a Day Ahead of Schedule drugs.com
January 18, 2022
It was slated to debut on Wednesday, but the federal government quietly launched its website for Americans to order free at-home COVID-19 tests one day early.
Too Soon to Tell if Omicron Will End Pandemic: Fauci drugs.com
January 18, 2022
It is too soon to determine whether omicron's rapid spread will turn a pandemic virus into an endemic disease, America's top infectious disease expert says.
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19 drugs.com
January 18, 2022
The addition of a P2Y12 inhibitor to anticoagulant therapy does not improve organ support-free days among non-critically ill patients hospitalized for COVID-19...
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial prnasia
January 17, 2022
The Philippines has approved Recombinant Two-Component COVID-19 Vaccine (ReCOV) developed by Jiangsu Recbio Technology Co., Ltd. ("Recbio") for Phase II/III clinical research.
WHO recommends GSK-Vir and Lilly’s drugs for Covid-19 treatment Pharmaceutical-Technology
January 17, 2022
The World Health Organization (WHO) has recommended the use of two new drugs by GlaxoSmithKline (GSK) and Vir Biotechnology and Eli Lilly to treat Covid-19.
WHO recommends two new drugs to treat COVID-19 ExpressPharma
January 17, 2022
The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable they will be...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page